Journal of Medical Economics
Volume 25, 2022 - Issue 1
Open access
15,496
Views
21
CrossRef citations to date
0
Altmetric
Respiratory Medicine
Tezepelumab compared with other biologics for the treatment of severe asthma: a systematic review and indirect treatment comparison
Andrew Menzies-Gowa Royal Brompton and Harefield Hospitals, London, UK
, Jason Steenkampb EVERSANA, Burlington, Canada
, Sumeet Singhb EVERSANA, Burlington, Canada
, Wilma Erhardtc AstraZeneca, Gothenburg, Sweden
, Jennifer Rowelld AstraZeneca, Cambridge, UK
, Pallavi Ranee Amgen Inc, Thousand Oaks, USA
, Neil Martind AstraZeneca, Cambridge, UK
, Jean Pierre Llanose Amgen Inc, Thousand Oaks, USA
& Anna Quintond AstraZeneca, Cambridge, UKCorrespondence[email protected]
show all
Pages 679-690
|
Received 06 Apr 2022, Accepted 03 May 2022, Published online: 03 Jun 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.